This study included 307 subjects aged from 4 to 8 years. 176 subjects of those were allergic conjunctivitis, and 131 subjects were normal control.
Allergic conjunctivitis always happened in spring and autumn,seldom in winter. A larger percentage of patients were PAC (18.18%), who happened at all seasons, throughout the whole year without remission.
The results of skin reaction to dermatophagoides pteronyssinus and dermatophagoides farinae were highly matched, which indicated these two dust mites may have the same allergic ingredients. Although there was no correlation was found between the ocular symptom/sign scores and the grades in SPT response to dust mite allergens, grade 3 was the most common. And we found there was a significantly positive correlations between scores of ocular symptom/sign and duration of the disease. And we found that the longer duration the disease lasted, the higher scores patients get (whether the symptoms or signs). It meant that lasting and allergic reaction to dust mite allergens, moderate or severer, may be responsible for the ocular symptoms and signs. This may explain that in our clinical, we found the ocular symptoms and signs were more severe in the children who were under desensitization treatment of dust mite allergens.
Psychiatric factors may cause eyes blinking [18]. Eye blinking may have a transient tic disorder. When the course lasted long, it may be confused with tic, which could have some influence on the somatic symptoms and the patient’s attention [19]. Psychiatric consultation may be necessary for children with long-term and frequent eye blinking. Incontrollable rubbing eyes would make the situation worse. So, it was important to provide proper intervention to alleviate their symptoms and signs.
In this questionnaire, the results showed that when in children, the morbidity of allergic conjunctivitis was higher in male than female. Generally, female would pay more attention to hygiene than male, this difference was especially obvious between boys and girls. We speculated that hygienic conditions maybe the key to the incidence of allergic conjunctivitis.
The results showed that the number of children in the case group who ever had exclusive breast-fed was far less than the control group. The mean duration of exclusive breast-feeding in case group was also shorter than the duration in control group. So, we suspected that exclusive breast-feeding maybe a protective factor for allergic conjunctivitis. Breast-feeding 4 months or more could reduce the risk of eczema and onset of the allergy marched to age 4, which was reported by Kull et al [20]. So we speculated that breast-feeding may play an important part in the onset of the allergic diseases and the duration of allergic reaction.
There was no correlation between the duration of exclusive breast-feeding and the age of onset or the degree of allergic reaction performed in SPT.
In addition, we found parental allergy history in the case group was significantly higher than that in control group, allergic rhinitis was the most common one, which meant parental allergy history especially with allergic rhinitis was a risk factor for their children to get allergic conjunctivitis.
Therefore, breast-feeding should be recommended as one possible way to reduce the risk of onset of allergic conjunctivitis, prolonged breast-feeding was particularly recommended for these infants with parental allergy history. These children with parental allergy history deserved special attention in the clinical treatment, especially during the inquiry.
Systemic allergic diseases were closely related with allergic conjunctivitis. According to our study, allergic rhinitis was the most common, followed by eczema, asthma and urticaria papulosa. So, inquiring of the systemic allergic history was necessary in clinic, especially for these children without typical symptoms and signs or too young to explain himself, this would help us to diagnose and give proper treatment.
Interestingly, children with the adenoidal hypertrophy (ATH) were more common in case group, which means allergic conjunctivitis may be a risk factor for ATH, this result was consistent with Modrzynski Metal [21–23]. Seasonal and perennial allergic conjunctivitis were considered to be associated with type I hypersensitivity reactions [24]. The conjunctiva located in the upper extremity of the respiratory system, the nasolacrimal duct was a drainage system in to the nose [25]. Allergens and allergic mediators would drain to the nose by this pathway, generating nasal symptoms. The conjunctiva and the nose made up an entire system [1, 2, 5–8]. Therefore, the coexistence of allergic rhinitis and conjunctivitis happened repeatedly.
Xiaowen Zhang et al found the rate of sIgE presenting in adenoids or tonsils was significantly higher than that in the serum of childhood ATH, which suggested a role of local atopy [26, 27]. Allergy control may play some role in reducing the rate of adenotonsillectomy in children suffering from allergic reactions caused by ATH [28]. We assumed that in these children suffering from PAC combined with ATH, effectively controlment of PAC could alleviate the symptoms of ATH and reduce the rate of adenotonsillectomy. And children with ATH should have an ophthalmic exam to determine whether suffering from allergic conjunctivitis, in order to give proper synchronous treatments.
The symptoms of SAC and PAC in children were typical mainly including rubbing eyes, itching, blinking and redness. Nearly half of children had rubbing eyes, itching, and blinking, which were the top three symptoms. The top three clinical signs of allergic conjunctivitis were chemosis, tarsal conjunctival papillary hypertrophy, and bulbar conjunctival hyperemia, but they were not specific. Discoloration, limbal hypertrophy, mucus secretions and keratitis were the characteristic signs. Discoloration and limbal hypertrophy were always happened, the circumference of it could become thickened and opaque. The keratitis and mucus secretions were rare in our findings and often happened when rubbing eyes were uncontrollable [6]. The ocular surface inflammation usually was driven by mast cell which led to rubbing eyes, itching, blinking and redness in the acute phase [29]. So, PAC were traditionally treated with combination anti-histamine mast cell stabilizers. But in severe subjects, these drugs were not effective. A late-phase response developed by eosinophilia and neutrophilia should be considered, which may lead to remodel the ocular surface tissues manifesting discoloration and limbal hypertrophy.
Lately, in clinical, milder cases can be treated with short-term topical ophthalmic therapy such as decongestant/antihistamine combination, mast cell stabilizer, or multi-action agent. Moderate to severe cases may require longer use of the above agents or the addition of an oral antihistamine. Refractory cases may need the use of topical ophthalmic corticosteroids and/or immunotherapy. Corticosteroids had been proven effective, but the potential side effects including increased intraocular pressure, cataracts and corneal melts would restrict the duration of corticosteroid usage. After stopping the corticosteroids, the disease would be back and forth. Even though nasal corticosteroids were not a first-line treatment for allergic conjunctivitis, in patients with rhinoconjunctivitis, nasal mometasone furoate and fluticasone furoate had been shown to relieve the associated conjunctival symptoms. Although intranasal corticosteroids could improve ocular symptoms, the involved mechanism(s), probably related to reduction of nose-ocular reflex, still was unknown.
Inventing more effective medicine to treat seasonal and perennial allergic conjunctivitis were extremely urgent. Better understanding of the clinical parameters of the syndromes induced by allergic conjunctivitis and the cell and molecular basis of this disease was important to explore both safe and effective treatment.
Children were different from adults. As more we learned about the allergic conjunctivitis in children, it may reduce the misdiagnose and misuse of antibiotics.